Orignal Articles
Copyright ©2009 The WJG Press and Baishideng.
World J Gastroenterol. May 14, 2009; 15(18): 2234-2239
Published online May 14, 2009. doi: 10.3748/wjg.15.2234
Figure 5
Figure 5 PPARγ antagonist GW9662 blocked the effects of ADFMChR on PPARγ and NF-κB protein expression in HepG2 cells. A: PPARγ; B: NF-κB. HepG2 cells were pretreated with 10.0 &mgr;mol/L GW9662 for 30 min, then exposed to 3.0, 30.0 &mgr;mol/L ADFMChR for 24 h, respectively (mean ± SD, n = 3).